We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals
ALNY

374 hedge funds and large institutions have $16.5B invested in Alnylam Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 74 funds opening new positions, 137 increasing their positions, 109 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more first-time investments, than exits

New positions opened: 74 | Existing positions closed: 28

40% more capital invested

Capital invested by funds: $11.8B → $16.5B (+$4.72B)

38% more call options, than puts

Call options by funds: $154M | Put options by funds: $111M

26% more repeat investments, than reductions

Existing positions increased: 137 | Existing positions reduced: 109

13% more funds holding

Funds holding: 330 → 374 (+44)

1.28% more ownership

Funds ownership: 95.96% → 97.24% (+1.3%)

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

Holders
374
Holders Change
+44
Holders Change %
+13.33%
% of All Funds
7.67%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
74
Increased
137
Reduced
109
Closed
28
Calls
$154M
Puts
$111M
Net Calls
+$42.4M
Net Calls Change
+$22.3M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$186M
2
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$143M
3
Blackstone Inc
Blackstone Inc
New York
+$125M
4
American Century Companies
American Century Companies
Missouri
+$79.6M
5
BlackRock
BlackRock
New York
+$74.2M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$245M
2
FCM
Farallon Capital Management
California
-$60.7M
3
Dodge & Cox
Dodge & Cox
California
-$52.5M
4
MC
Maverick Capital
Texas
-$30.5M
5
AG
Artal Group
Luxembourg
-$27M
Name Holding Trade Value Shares
Change 		Change in
Stake
SAM
251
Shell Asset Management
Netherlands
$472K -$177K -1,315 -29%
DCM
252
Driehaus Capital Management
Illinois
$467K +$23.2K +172 +6%
Squarepoint
253
Squarepoint
New York
$464K -$1.16M -8,604 -73%
AIG
254
American International Group
New York
$463K +$107K +796 +34%
GT
255
Greenleaf Trust
Michigan
$459K – – –
Fiera Capital (Canada)
256
Fiera Capital (Canada)
Quebec, Canada
$452K +$412K +3,055 New
CA
257
Clearstead Advisors
Ohio
$444K – – –
TAM
258
Tocqueville Asset Management
New York
$444K – – –
HKAM
259
Horizon Kinetics Asset Management
New York
$444K +$404K +3,000 New
JPMIA
260
J.P. Marvel Investment Advisors
Massachusetts
$434K – – –
Caisse de Depot et Placement du Quebec (CDPQ)
261
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$430K -$162K -1,200 -29%
BM
262
Brandywine Managers
Delaware
$430K – – –
SMH
263
Sanders Morris Harris
Texas
$417K +$377K +2,800 New
HS
264
HighVista Strategies
Massachusetts
$415K +$378K +2,805 New
BCV
265
Banque Cantonale Vaudoise
Switzerland
$414K +$40.3K +299 +12%
CC
266
Centiva Capital
New York
$400K +$289K +2,141 +381%
QI
267
QS Investors
New York
$386K +$27K +200 +8%
ALAM
268
Asahi Life Asset Management
Japan
$353K -$232K -1,720 -42%
AII
269
AGF Investments Inc
Ontario, Canada
$342K +$310K +2,298 +28,725%
OC
270
Oppenheimer & Co
New York
$341K +$310K +2,300 New
AC
271
Athanor Capital
New York
$340K +$310K +2,296 New
Arrowstreet Capital
272
Arrowstreet Capital
Massachusetts
$326K +$297K +2,200 New
JMPWA
273
JP Morgan Private Wealth Advisors
California
$307K +$279K +2,072 New
PCM
274
Prelude Capital Management
New York
$306K +$279K +2,066 New
WAM
275
World Asset Management
Michigan
$305K +$10.1K +75 +4%
9 10
11
12 13

ALNY Hedge Fund Activity: Q2 2020 in Review

374 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Alnylam Pharmaceuticals (ALNY) for Q2 2020, worth a combined $16.5B — up 40% from $11.8B a quarter earlier.

Buyers outnumbered sellers: 74 funds opened new ALNY positions and 28 closed out — a net gain of 46 holders — while 137 added to existing stakes and 109 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $186M. The largest seller was Wellington Management Group, cutting an estimated $245M.

  • 374 institutional investors held Alnylam Pharmaceuticals (ALNY) as of Q2 2020, up from 330 in Q1 2020.
  • Funds reported $16.5B of Alnylam Pharmaceuticals stock for Q2 2020, up 40% quarter-over-quarter.
  • 74 funds opened new Alnylam Pharmaceuticals positions in Q2 2020 and 28 closed out, a net change of +46 holders.
  • The largest Alnylam Pharmaceuticals buyer in Q2 2020 was JP Morgan Chase, an estimated $186M added.
  • The largest Alnylam Pharmaceuticals seller in Q2 2020 was Wellington Management Group, an estimated $245M sold.

Based on aggregated 13F filings for Q2 2020.